Saffron and ADHD: What the Research Says in 2026
Search for saffron and ADHD and you will find headlines saying a cooking spice performed as well as Ritalin. That is a fair thing to want to check on.
The research is thinner than the headlines suggest. Four studies exist, they cover about 243 people between them, and the way they were built matters as much as what they found.
One gap shapes everything below. Three of the four studies enrolled 6 to 17 year olds, so anyone researching this for adult ADHD has exactly one study that speaks to their situation, and it came out split.
The short answer
- Four studies have tested saffron in people with ADHD, about 243 people in total, and only one of them was in adults
- Results were encouraging, but the studies were small and short, and two of them share a researcher with the review that assessed them
- Only one study randomly split people into a saffron group and a medication group. It had 54 children, and roughly four in five of them were boys
- No study in children included a placebo group, which is how researchers normally separate a real effect from an expected one
- Every study used 20 to 30mg a day. Higher figures circulate online and they are wrong
- Saffron is not an ADHD treatment. No regulator has approved it for that and no medical guideline recommends it
Anyone considering it should raise it with the clinician managing the diagnosis. There is a list of questions to ask them further down this page.
What is on this page
- The four studies, side by side
- The study behind the headlines
- Why the missing placebo group matters
- How saffron might work
- What the research misses about women
- What we still do not know
- The dose, and a dangerous number going around
- Safety and drug interactions
- Questions to ask your doctor
- Common questions
The four saffron ADHD studies, side by side
We looked for every published human trial of saffron in ADHD in July 2026 and found four. The most recent was published in 2022, and we found no registered trial currently underway, though not every national trial registry could be searched. If you know of another study, tell us and we will add it.
A note on names first, because three of them point at the same thing.
ADD is the older term for what is now diagnosed as ADHD, predominantly inattentive presentation, the version without obvious hyperactivity. The diagnostic manual folded ADD into ADHD in 2013.
Adult ADHD is not a separate condition either. It is the same diagnosis carried into adulthood, though it often looks different by then, with childhood hyperactivity settling into restlessness and the difficulties showing up as disorganization, poor time management and trouble finishing things. The Mayo Clinic overview of adult ADHD covers the symptom picture.
All three terms lead to the same four studies described below.
Two terms come up repeatedly in the table. A randomized study sorts people into groups by chance, which keeps the groups comparable. A placebo-controlled study gives one group a placebo, a capsule with nothing active in it, so researchers can see how much improvement came from the treatment itself.
Chart 0
Four studies, compared
The same five questions asked of each one
Every card carries the same attributes in the same order, so you can compare down the stack. The marker row at the foot of each card is the methodological record.
Baziar 2019
Iran · 2019
- Who
- 54 children, ages 6 to 17, 20% girls
- Saffron dose
- 20mg under 30kg, 30mg above
- How long
- 6 weeks
- Compared with
- Methylphenidate, the medicine in Ritalin
- Found
- Both groups improved by a similar amount and the study could not tell them apart
Met these standards
- Randomized
- Placebo group
- Head to head
Khaksarian 2021
Iran · 2021
- Who
- 70 children, ages 6 to 16
- Saffron dose
- 20 to 30mg, added on top of medicine
- How long
- 8 weeks
- Compared with
- The same medicine, alone
- Found
- The group taking both scored better at weeks 4 and 8. Everyone was on medication
Met these standards
- Randomized
- Placebo group
- Head to headadd-on
Blasco-Fontecilla 2022
Spain · 2022
- Who
- 63 children, ages 7 to 17
- Saffron dose
- 30mg
- How long
- 3 months
- Compared with
- Long-acting methylphenidate
- Found
- Similar overall, with saffron ahead on hyperactivity and the medicine ahead on focus
Met these standards
- Randomized
- Placebo group
- Head to head
Pazoki 2022
Iran · 2022
- Who
- 56 adults
- Saffron dose
- 15mg twice a day, added on top of medicine
- How long
- 6 weeks
- Compared with
- A placebo, with everyone also taking medicine
- Found
- Split. One questionnaire showed a real difference and the other did not
Met these standards
- Randomized
- Placebo group
- Head to headadd-on
numilove.com
Only Baziar randomly compared saffron against medication. The Spanish study compared the two but did not randomize anyone. The other two were add-on studies where every participant took medication, and the question was whether saffron changed anything on top.
So the claim that saffron works as well as ADHD medication traces back to a single study of 54 children.
The study behind the headlines
Baziar and colleagues, March 2019. Fifty-four children aged 6 to 17 at a clinic in Tehran, about one in five of them girls. Half took saffron and half took methylphenidate for six weeks, with parents and teachers rating symptoms at the start, at three weeks and at six.
Both groups improved substantially. Parent scores dropped about 23 points in each group and teacher scores dropped about 9 in each. The gap between saffron and the medicine was too small to be meaningful, which is what "as effective as" turns out to mean here.
Fifty-four children is a small trial, and small trials routinely fail to detect differences that genuinely exist. So the finding is that this study could not separate saffron from methylphenidate, which is a weaker claim than saying the two perform the same.
Side effects came up less often with saffron, 16 percent against 46 percent for appetite loss or sleep trouble, though that gap also fell within the range of chance.
Child psychiatrist Jess Levy MD reviewed the study for The Carlat Child Psychiatry Report in November 2019. She wrote that the results "are so impressive that they seem too good to be true," and pointed to the missing placebo group, the medication dosing, and the fact that supplements are not checked for consistency the way medicines are.
Why the missing placebo group matters
ADHD symptoms improve substantially on a placebo, by enough to swamp a small trial.
Castells and colleagues, January 2022 pooled 94 studies covering 6,614 people who received a placebo. Symptom scores fell by an average of 23.1 percent among people taking a capsule with nothing in it.
Some of that is real, because symptoms fluctuate and adults who expect improvement in a child tend to see it. Either way, a large improvement in an ADHD study is where the measurement starts, not where it lands.
Both groups in the Baziar study improved a great deal. Without a placebo group, nobody can say how much of that either treatment caused.
How saffron might work
Saffron was tested against a stimulant because the two act on some of the same brain chemistry.
Nerve cells communicate using chemical messengers and then reabsorb them, a process called reuptake. Methylphenidate blocks the reuptake of dopamine and norepinephrine by binding to the transporter proteins that carry them, according to the NIH StatPearls monograph. More of both messengers stay active in the gaps between nerve cells, and more signal reaching the parts of the brain that handle attention and impulse control is the intended effect.
Laboratory research on saffron's two main active compounds, crocins and safranal, suggests they slow the reuptake of dopamine and serotonin, through broadly similar action at a far milder scale.
Dopamine sits in both lists, which is what prompted researchers to run the comparison in the first place.
The third messenger differs, and that difference may explain the most unexpected result in this literature. Norepinephrine drives sustained attention, which is why one ADHD medication, atomoxetine, targets it alone. A compound that misses norepinephrine would be expected to do less for focus, while serotonin has more to do with restlessness and mood, and restlessness is where saffron scored better in the Spanish study.
Treat that as a hypothesis. None of the four studies measured anyone's neurotransmitter levels, they measured symptom questionnaires, and a mechanism that explains a result neatly can still turn out to be the wrong explanation. Our guide to dopamine, serotonin and norepinephrine covers what each messenger does.
What the research misses about women
ADHD gets diagnosed in boys far more often than girls, at a ratio of roughly three or four to one in childhood. By adulthood that ratio evens out to something close to one to one. A Swedish population study of 85,330 people with ADHD found women were diagnosed on average four years later than men.
The usual explanation is that girls more often show the inattentive presentation, the form once called ADD, which looks like forgetfulness and disorganization instead of disruption, so teachers and parents miss it. Many women also learn to mask symptoms, and get treated for the resulting anxiety or depression while the ADHD goes unexamined.
Set that against the saffron research and a real gap appears.
The one randomized head-to-head study enrolled 54 children, about 20 percent of them girls. So the trial that generated every "as good as Ritalin" headline studied roughly 43 boys and 11 girls, none of them adults.
A woman diagnosed at 35 who reads about saffron for ADHD is reading data drawn almost entirely from children, and mostly from boys. That does not mean the findings cannot apply to her. It means nobody has checked. Sex differences in how ADHD presents are well documented, and none of the four studies were built to detect them.
What we still do not know
- Whether saffron beats a placebo in children. No pediatric study has tested that, and against a 23.1 percent placebo response it is the central gap in the literature
- Whether the effect survives a larger trial. About 243 people have been studied in total and the biggest single study had 70
- Anything past three months. ADHD lasts years and the longest study ran a single season
- How saffron performs on its own in an adult. The only adult study added it to medication people were already taking
- Whether it works differently in women. See above
- Whether unconnected teams get the same result. Shahin Akhondzadeh co-authored two of the four studies and the 2024 review that assessed them, which leaves the findings unreplicated by fully independent groups
- What was actually in the capsules. Most of the studies never report the strength of the extract they used
A 2024 review in the Journal of Attention Disorders concluded that saffron looked effective alone or alongside medication with no significant safety concerns, and called for larger studies. Its summary counts four studies and 118 patients, while the four described above enrolled around 243 between them. Its full text sits behind a paywall and we could not confirm which studies it included, so its conclusion is best read as the authors' judgment rather than a tally of the field.
The dose, and a dangerous number going around
Every human study used 20 to 30mg of saffron extract per day. Children under 30kg received 20mg, children above it received 30mg, and adults received 30mg. Nobody has tested more.
Several supplement pages cite a study in which adults took 50mg per kilogram of body weight per day. For a 70kg adult that comes to 3,500mg of saffron daily.
According to the Drugs.com natural products monograph, saffron intake up to 1.5g a day has not been linked to adverse effects, doses above 5g are considered toxic, and around 20g is considered lethal. Doses between 1.2 and 2g have produced nausea, vomiting and bleeding. A 3,500mg daily dose sits inside the range where harm has been documented.
Doses expressed per kilogram of body weight at that scale come from animal research, where the convention is normal, and they do not carry over to people. Any page recommending saffron in the hundreds or thousands of milligrams has an error in it.
A note on what we sell. We make a saffron supplement. It has not been studied for ADHD, nothing on this page should be read as a reason to try it for that, and the 88.5mg marked on the chart above is not a dose any of these studies used. What we can show is what is in the capsule. Every batch of Saffron360 is tested by an independent laboratory to confirm the extract is genuine Crocus sativus and not cut with something cheaper, and the report for your own bottle opens from the QR code on the label.
Saffron safety and drug interactions
Across the four studies, side effects at 20 to 30mg a day were similar to or milder than the comparison medication. Reported effects at supplement doses include stomach upset, headache, drowsiness and appetite changes.
Several risks sit outside what the studies measured.
- Saffron can interact with antidepressants, blood thinners and blood pressure medication, and ADHD often arrives alongside anxiety or depression, so a lot of people fall into that overlap
- No study has tested saffron with Adderall or Vyvanse, which are amphetamines rather than the methylphenidate used in every trial
- Supplemental doses are not advised during pregnancy or nursing
- Supplements are not verified for accuracy before sale, so a label figure and a capsule's contents are separate questions. Ask any brand for their batch test results before buying anything
- The main risk in this decision is usually not saffron itself. It is delaying or replacing a treatment with decades of evidence behind it
Questions to ask your doctor about saffron and ADHD
Raising this at an appointment goes better with specific questions. These six get a useful answer.
- Given what you know about my situation, is there any reason saffron would be a bad idea for me?
- Would it interact with anything I am currently taking?
- If I tried it, how would we tell whether it was doing anything, and over what period?
- What should I watch for and report back to you?
- Is there anything with stronger evidence you would rather I tried first?
- Does anything about my current plan need to change if I add it?
Any decision involving a child belongs with their pediatrician first. Dosing in children, growth, interactions and the cost of delaying effective treatment all need a clinician who knows the patient.
Common questions about saffron and ADHD
Does saffron help with ADHD?
Four small studies have tested it. One randomly compared saffron with ADHD medication in 54 children and could not tell the two apart after six weeks. Two studies found benefits when saffron was added to existing medication, though one of those, in adults, showed a difference on one questionnaire and not another. No study in children used a placebo group and about 243 people have been studied in total. Saffron is not an ADHD treatment and no regulator has approved it for that.
How much saffron did the ADHD studies use?
Every study used 20 to 30mg of saffron extract per day. Children under 30kg took 20mg, children above it took 30mg, and adults took 30mg, sometimes split into two doses. Figures such as 50mg per kilogram of body weight are not human doses and appear to come from animal research.
Is saffron as effective as Ritalin or Adderall?
No study has compared saffron with Adderall, which is an amphetamine. One study of 54 children compared it with methylphenidate, the medicine in Ritalin and Concerta, and found no meaningful difference over six weeks. That study had no placebo group and was small enough that it would likely have missed a real difference, so it shows what the study could detect rather than that the two match.
Does saffron help adult ADHD?
One study has tested it in adults. Pazoki and colleagues gave 56 adults either saffron or a placebo on top of the methylphenidate they were already taking, for six weeks. The result split across the two questionnaires used, with a significant difference on one and none on the other. No study has tested saffron on its own in an adult, so nothing shows what it does without medication alongside it. The other three studies enrolled children, which is a real limit on what any of this says about adult ADHD.
Does saffron work for ADHD in women?
Nobody has tested that directly. Three of the four studies were in children, and the one randomized head-to-head trial was about 20 percent girls, so roughly 43 boys and 11 girls. Women are diagnosed with ADHD on average four years later than men and more often show the inattentive presentation, but none of the saffron studies were designed to detect differences by sex.
Does saffron help with ADD?
ADD and ADHD are the same condition under two names. What used to be called ADD is now diagnosed as ADHD, predominantly inattentive presentation, so the four studies described here are the whole evidence base for both. None of them separated results by presentation type, so nothing shows whether saffron affects the inattentive form differently from the hyperactive one.
Have saffron ADHD studies been done in children?
Yes. Three of the four studies involved children and teenagers aged 6 to 17, taking 20 to 30mg a day under medical supervision. That describes what researchers did in a controlled setting and is not a recommendation. Giving any supplement to a child for a diagnosed condition is a decision for their pediatrician, who can weigh interactions against the risk of delaying treatment that already works.
How long does saffron take to affect ADHD symptoms?
Studies that checked partway through saw differences appearing around weeks 3 to 4 and continuing to the end at six or eight weeks. The longest study ran three months, and nothing is known beyond that.
What are the side effects of saffron?
At supplement doses, reported effects include mild stomach upset, headache, drowsiness and appetite changes. In the 2019 study, 16 percent of the saffron group reported appetite loss or sleep trouble against 46 percent taking methylphenidate, a gap that fell within the range of chance. Allergic reactions are possible but uncommon.
Can you take saffron with ADHD medication?
Two of the four studies combined them under medical supervision without significant safety problems, which is a long way from being safe to do unsupervised. No study has tested saffron with amphetamine-based medication such as Adderall or Vyvanse. Saffron may also interact with antidepressants, blood thinners and blood pressure medicine, so ask whoever prescribes first.
How does saffron affect dopamine and serotonin?
Laboratory and animal research suggests saffron's crocins and safranal slow the reuptake of dopamine and serotonin, leaving more of both active between nerve cells, and that safranal also interacts with serotonin receptors directly. None of the four ADHD studies measured neurotransmitter levels, so this is a mechanism nobody has confirmed in people.
Does saffron work the same way as ADHD medication?
Not quite. Methylphenidate blocks the reuptake of dopamine and norepinephrine. Saffron appears to act on dopamine and serotonin, and far more gently. The shared effect on dopamine is why the two were ever compared, and the difference on the third messenger may explain why the Spanish study found the medicine ahead on focus and saffron ahead on hyperactivity.
Is saffron regulated the way ADHD medication is?
No. ADHD medications go through years of trials and manufacturing oversight before approval, while supplements can be sold without proving what is in them. That is why independent lab testing of each batch matters and why a label figure is not a guarantee.
Where this leaves the evidence
Saffron is an early signal. One randomized head-to-head study in 54 mostly male children, two add-on studies, one comparison that skipped randomization, no placebo group in any study of children, and nothing past three months.
That is a stronger position than most things sold for focus and attention occupy, and it falls well short of what would justify calling saffron a treatment. No regulator or medical guideline currently describes it as one.
Readers wanting the biology underneath all this can start with our guides to the three chemicals that shape mood and focus and what happens when dopamine runs low. GABA covers the compound behind saffron's calming reputation, and supporting your brain chemistry day to day covers the practical side.
Written by JT Root, NASM-CNC, Certified Nutrition Coach and founder of Numi Naturals. Last reviewed July 27, 2026.
How we researched this article. We searched the published literature for human clinical trials of saffron in ADHD in July 2026 and found four. Every study fact on this page was checked against the original publication, not against other articles about it, and where we could not reach a full text we say so. If you find an error here, tell us and we will correct it.
This article reports published research. It is not medical advice and not a treatment recommendation. ADHD is a medical diagnosis that should be assessed and managed by a qualified healthcare provider. Do not start, stop or change any treatment based on something you read online.
*These statements have not been evaluated by the Food and Drug Administration. No product is intended to diagnose, treat, cure, or prevent any disease.